Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost/Timolol Fixed Combination in Glaucoma and Ocular Hypertension
NCT00941096Phase 4Completed
- Sponsor
- University Hospital of Larissa
- Start
- Jul 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bimatoprost + timolol in primary open-angle glaucoma (POAG), Exfoliative Glaucoma (PEG) and ocular hypertension, sponsored by University Hospital of Larissa. Primary endpoint: Mean Diurnal Intraocular Pressure at 10 weeks. Started Jul 2009; status: completed.
02
Drugs
bimatoprost + timolol
03
Conditions
primary open-angle glaucoma (POAG)Exfoliative Glaucoma (PEG)ocular hypertension
Beyond the preview
Go deeper on NCT00941096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00941096.